Skip to main content
Study

Reducing anticoagulant medication adverse events and avoidable patient harm.

Jennings HR, Miller EC, Williams TS, et al. Reducing anticoagulant medication adverse vents and avoidable patient harm. Jt Comm J Qual Patient Saf. 2008;34(4):196-200.

Save
Print
April 9, 2008
Jennings HR, Miller EC, Williams TS, et al. Jt Comm J Qual Patient Saf. 2008;34(4):196-200.

Hospitalized patients receiving anticoagulants such as warfarin are at high risk for adverse drug events, and reducing the incidence of such errors is one of the Joint Commission's 2008 National Patient Safety Goals. In this study, a hospital system instituted several patient safety measures, including an anticoagulation service and executive walk rounds, to target anticoagulant-related medication errors. The 3-year project resulted in a significant reduction in both bleeding and thrombotic episodes. A case of a warfarin-related adverse event is discussed in an AHRQ WebM&M commentary.

Save
Print
Cite
Citation

Jennings HR, Miller EC, Williams TS, et al. Reducing anticoagulant medication adverse vents and avoidable patient harm. Jt Comm J Qual Patient Saf. 2008;34(4):196-200.